Emily Bergsland, MD
Specialty: Medical Oncology
UCSF Helen Diller Family Comprehensive Cancer Center
Multidisciplinary NET treatment program
Mission Hall, 550 16th Street Box 3211
San Francisco, California
Patient scheduling: (415) 353-9888
90%
of practice is NET patients
20
years’ experience treating NETs
52
published NET-related research papers
Emily Bergsland, MD is actively involved in neuroendocrine cancer research.
Research interests:
NET clinical trials, outcomes in NET patients, studies of NET biology
Subspecialty areas:
- Lung NETs
- GI NETs
- Pancreatic NETs
- Pheochromocytoma/Paraganglioma
- Liver metastasis
- Neuroendocrine carcinoma (poorly differentiated)
NET-related professional association memberships:
- North American Neuroendocrine Tumor Society (NANETS)
- European Neuroendocrine Tumor Society (ENETS)
- American Association of Cancer Research (AACR)
- NCCN NET Guidelines Panel Member
Leadership role(s):
- North American Neuroendocrine Tumor Society (NANETS)
- NCCN Guidelines Panel Member
NETRF-funded research
Emily Bergsland, MD, received a 2018 NETRF Investigator Grant for the study “New strategies to improve drug development for carcinoid tumors.”
Presentations by Emily Bergsland, MD
Emily Bergsland, MD, UCSF
Understanding Clinical Trials Watch Video